vimarsana.com

Page 13 - எலும்பு மஜ்ஜை மாற்று அறுவை சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Hemoglobinopathies Market Share to hit at a CAGR of 10 1% by 2027

Search jobs Global Hemoglobinopathies Market Share to hit at a CAGR of 10.1% by 2027 Hemoglobinopathies Market by Type (Sickle Cell Disease, Thalassemia, Others), Diagnosis (Genetic Testing, Red Blood Cell (RBC) Count Test,Hemoglobin Isoelectric (Hb IEF) Focusing, Hemoglobin By High Performance Liquid Chromatography (HPLC) Test,Hemoglobin Solubility Test, Hemoglobin Electrophoresis (Hb ELP) Test), Therapy (Blood Transfusion,Bone Marrow Transplant, Iron Chelation Therapy, Others), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, andForecast 2020to 2027 is the latest report by  Fior Markets which is the fastest growing market research company. The report provides a comprehensive scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future market prospects. The report features real-time developments in the global Hemoglobinopathies marke

Covaxin demand grows among Indians after efficacy results

Covaxin demand grows among Indians after efficacy results ​ By IANS | Published on ​ Tue, Mar 9 2021 18:12 IST | ​ 0 Views Covaxin generated excellent safety data, says Bharat Biotech. Image Source: IANS News New Delhi, March 9 : As India s vaccination drive against Covid-19 gathers momentum, the clouds of initial hesitancy about receiving Covaxin, developed by Hyderabad-based Bharat Biotech, has now cleared, raising demand and acceptability of the country s first indigenous vaccine against the disease. While a major boost to the vaccine s acceptability came after Prime Minister Narendra Modi received the first dose of the vaccine earlier this month, the publication of efficacy results gave the vaccine another shot in the arm.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.